| Dr Jeffery Edward Fitzthum, MD | |
|
549 Main St, Edmonds, WA 98020-3149 | |
| (425) 967-6974 | |
| (425) 967-5480 |
| Full Name | Dr Jeffery Edward Fitzthum |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 549 Main St, Edmonds, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962434142 | NPI | - | NPPES |
| 8254245 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD00038676 (Washington) | Primary |
| 111N00000X | Chiropractor | CH00034708 (Washington) | Secondary |
| Entity Name | Martin R Hehn Dc Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669701355 PECOS PAC ID: 1658413133 Enrollment ID: O20100121000397 |
News Archive
While investigating the impact of Hurricane Katrina on New Orleans evacuees, a group of UCLA researchers stumbled across something they had not been looking for the deep level of distrust the largely minority victims felt toward public health authorities.
A small clinical trial led by researchers at UC San Diego School of Medicine and VA San Diego Healthcare System (VASDHS) found that patients with advanced heart failure and type 2 diabetes showed improved mitochondrial structure after three months of treatment with epicatechin-enriched cocoa. Epicatechin is a flavonoid found in dark chocolate.
An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.
Sanofi-aventis announced today the first Phase III results of the GetGoal clinical trial program assessing the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, as monotherapy in patients with type 2 diabetes. These results were presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffery Edward Fitzthum, MD 549 Main St, Edmonds, WA 98020-3149 Ph: (425) 967-6974 | Dr Jeffery Edward Fitzthum, MD 549 Main St, Edmonds, WA 98020-3149 Ph: (425) 967-6974 |
News Archive
While investigating the impact of Hurricane Katrina on New Orleans evacuees, a group of UCLA researchers stumbled across something they had not been looking for the deep level of distrust the largely minority victims felt toward public health authorities.
A small clinical trial led by researchers at UC San Diego School of Medicine and VA San Diego Healthcare System (VASDHS) found that patients with advanced heart failure and type 2 diabetes showed improved mitochondrial structure after three months of treatment with epicatechin-enriched cocoa. Epicatechin is a flavonoid found in dark chocolate.
An international study led by researchers from IMIM (Hospital del Mar Medical Research Institute) published in the journal Nature Communications has revealed that the intensity or efficiency of the activation of a protein called Notch, which is involved in the different phases of embryonic development, determines the fate of cells, i.e. if cells will form the aorta artery or blood (hematopoietic) stem cells. For artery cells, many Notch molecules need to be activated, whereas for hematopoietic cells many fewer are needed.
Sanofi-aventis announced today the first Phase III results of the GetGoal clinical trial program assessing the efficacy and safety of lixisenatide, a once-daily GLP-1 receptor agonist, as monotherapy in patients with type 2 diabetes. These results were presented at the European Association for the Study of Diabetes (EASD) 46th Annual Meeting in Stockholm, Sweden.
› Verified 7 days ago
David L Heard, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 21600 Hwy 99, Suite 255, Edmonds, WA 98026 Phone: 425-774-2628 Fax: 425-774-2676 | |
Leslie Monroe, PTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 21008 76th Ave W, Edmonds, WA 98026 Phone: 425-778-0107 | |
James R Babington, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 21616 76th Ave W Ste 212, Edmonds, WA 98026 Phone: 425-673-3820 Fax: 425-673-3821 |